RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.
作者信息
Ning Baitang, Yu Ai-Ming
机构信息
National Center for Toxicological Research, US Food and Drug Administration (NCTR), 3900 NCTR Road, HFT100, Jefferson, AR 72079, United States.
Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, 2700 Stockton Blvd, Suite 2130, Sacramento, CA 95817, United States.
出版信息
Biochem Pharmacol. 2021 Jul;189:114567. doi: 10.1016/j.bcp.2021.114567. Epub 2021 Apr 16.
Abstract
摘要
相似文献
1
RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.
Biochem Pharmacol. 2021 Jul;189:114567. doi: 10.1016/j.bcp.2021.114567. Epub 2021 Apr 16.
2
[Strategy for technology development of antibody therapeutics].
Nihon Yakurigaku Zasshi. 2016 Apr;147(4):235-40. doi: 10.1254/fpj.147.235.
3
"Design for Somebody" - Approach Enabling Mobile Technology Development.
Stud Health Technol Inform. 2017;242:669-675.
4
Science and technology development in Africa needs women.
Nat Hum Behav. 2020 Dec;4(12):1218. doi: 10.1038/s41562-020-00960-2.
5
Is Heart Failure a High Tech Industrial Giant?
J Card Fail. 2018 Nov;24(11):721-722. doi: 10.1016/j.cardfail.2018.11.009.
6
The Implementation of a Participatory Technology Development Process in a Clinical Setting.
Stud Health Technol Inform. 2022 Jun 29;295:67-70. doi: 10.3233/SHTI220662.
7
Hitting home with technology development for asthma.
Lancet Respir Med. 2016 Feb;4(2):102-3. doi: 10.1016/S2213-2600(15)00525-1. Epub 2015 Dec 19.
8
President's message: transcultural nursing and technology: really?
J Transcult Nurs. 2015 May;26(3):336. doi: 10.1177/1043659615571441. Epub 2015 Feb 12.
9
Despite or Due to the Cultural Revolution: The Development of Chinese Science, Technology, and Medicine in the 1960s and 1970s.
Endeavour. 2017 Sep;41(3):78-84. doi: 10.1016/j.endeavour.2017.06.012. Epub 2017 Jul 29.
10
Four Models to Guide AT Projects Intending Innovative Technology Development Outcomes.
Stud Health Technol Inform. 2017;242:421-428.
引用本文的文献
1
The Growing Class of Novel RNAi Therapeutics.
Mol Pharmacol. 2024 Jun 18;106(1):13-20. doi: 10.1124/molpharm.124.000895.
本文引用的文献
1
Small nucleic acids and the path to the clinic for anti-CRISPR.
Biochem Pharmacol. 2021 Jul;189:114492. doi: 10.1016/j.bcp.2021.114492. Epub 2021 Feb 27.
2
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges.
Biochem Pharmacol. 2021 Jul;189:114468. doi: 10.1016/j.bcp.2021.114468. Epub 2021 Feb 10.
3
Non-coding RNAs: Emerging from the discovery to therapeutic applications.
Biochem Pharmacol. 2021 Jul;189:114469. doi: 10.1016/j.bcp.2021.114469. Epub 2021 Feb 10.
4
A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells.
Biochem Pharmacol. 2021 Jul;189:114458. doi: 10.1016/j.bcp.2021.114458. Epub 2021 Feb 6.
5
Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid.
Biochem Pharmacol. 2021 Jul;189:114453. doi: 10.1016/j.bcp.2021.114453. Epub 2021 Feb 3.
6
The growth of siRNA-based therapeutics: Updated clinical studies.
Biochem Pharmacol. 2021 Jul;189:114432. doi: 10.1016/j.bcp.2021.114432. Epub 2021 Jan 26.
7
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.
Biochem Pharmacol. 2021 Jul;189:114424. doi: 10.1016/j.bcp.2021.114424. Epub 2021 Jan 19.
8
Targeting nucleolin by RNA G-quadruplex-forming motif.
Biochem Pharmacol. 2021 Jul;189:114418. doi: 10.1016/j.bcp.2021.114418. Epub 2021 Jan 16.
9
Flavonoid display ability to target microRNAs in cancer pathogenesis.
Biochem Pharmacol. 2021 Jul;189:114409. doi: 10.1016/j.bcp.2021.114409. Epub 2021 Jan 8.
10
The N-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression.
Biochem Pharmacol. 2021 Jul;189:114402. doi: 10.1016/j.bcp.2020.114402. Epub 2020 Dec 30.
Zotero 插件